Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | NSD2 | O96028 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.45 |
| ▸ | SLC2A2 | P11168 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18038995 | 0.99 | ALDH1A1 (0.49) | GAAALDH1A1LMNAPOLBHTT | |
| SCHEMBL18038989 | 0.90 | L3MBTL1 (0.56) | GAAALDH1A1LMNAPOLBTP53 | |
| SCHEMBL18038959 | 0.90 | L3MBTL1 (0.56) | GAAALDH1A1LMNAPOLBTP53 | |
| SCHEMBL18038954 | 0.90 | L3MBTL1 (0.56) | GAAALDH1A1LMNAPOLBTP53 | |
| SCHEMBL18038957 | 0.90 | ALDH1A1 (0.46) | GAAALDH1A1LMNAPOLBHTT | |
| SCHEMBL18039017 | 0.89 | POLB (0.51) | GAAALDH1A1POLBTP53MAPT | |
| SCHEMBL18038968 | 0.89 | PKM (0.56) | ALDH1A1LMNAPOLBHTTMAPK1 | |
| SCHEMBL18038944 | 0.87 | AKR1C3 (0.51) | GAAALDH1A1LMNAPOLBHTT | |
| SCHEMBL18038996 | 0.87 | ALDH1A1 (0.45) | GAAALDH1A1LMNAPOLBHTT | |
| SCHEMBL18038953 | 0.87 | L3MBTL1 (0.53) | GAAALDH1A1LMNAPOLBTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11311523-B2 | Pyridinone compound and use thereof | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2022-04-26 | — | — | US | disclosed |
| EP-3692992-A1 | METHOD OF SCREENING DOCK1-SELECTIVE INHIBITORS FOR CANCER TREATMENT | Kyushu University National University Corporation (JP) | 2020-08-12 | — | — | EP | disclosed |
| EP-3263133-B1 | PYRIDINONE COMPOUND AND USE THEREOF | UNIV KYUSHU NAT UNIV CORP (JP) | 2020-04-01 | — | — | EP | disclosed |
| US-20200061039-A1 | PYRIDINONE COMPOUND AND USE THEREOF | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2020-02-27 | — | — | US | disclosed |
| US-10406141-B2 | Pyridinone compound and use thereof | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2019-09-10 | — | — | US | disclosed |
| US-20180028515-A1 | PYRIDINONE COMPOUND AND USE THEREOF | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2018-02-01 | — | — | US | disclosed |
| EP-3263133-A1 | PYRIDINONE COMPOUND AND USE THEREOF | Kyushu University, National University Corporation (JP) | 2018-01-03 | — | — | EP | disclosed |
| WO-2016136985-A1 | PYRIDINONE COMPOUND AND USE THEREOF | 国立大学法人九州大学 | 2016-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180028515-A1 | PYRIDINONE COMPOUND AND USE THEREOF | DOCK5, DOCK2, CIB1 | GAA 4692/4885ALDH1A1 52/4885LMNA 3330/4885 |
| US-20200061039-A1 | PYRIDINONE COMPOUND AND USE THEREOF | DOCK5, DOCK2, CIB1 | GAA 4691/4885ALDH1A1 49/4885LMNA 3349/4885 |
| US-10406141-B2 | Pyridinone compound and use thereof | DOCK5, DOCK2, CIB1 | GAA 4692/4885ALDH1A1 52/4885LMNA 3330/4885 |
| US-11311523-B2 | Pyridinone compound and use thereof | DOCK5, DOCK2, CIB1 | GAA 4691/4885ALDH1A1 49/4885LMNA 3349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.